Medidata Solutions Inc.Find Ratings Reports
MEDIDATA SOLUTIONS INC's gross profit margin for the second quarter of its fiscal year 2019 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. MEDIDATA SOLUTIONS INC is extremely liquid. Currently, the Quick Ratio is 2.22 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.
During the same period, stockholders' equity ("net worth") has increased by 17.65% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY19||Q2 FY18|
|Net Sales ($mil)||180.46||155.91|
|Net Income ($mil)||7.89||16.59|
|Balance Sheet||Q2 FY19||Q2 FY18|
|Cash & Equiv. ($mil)||206.02||407.9|
|Total Assets ($mil)||1023.77||1102.79|
|Total Debt ($mil)||198.87||382.55|
|Profitability||Q2 FY19||Q2 FY18|
|Gross Profit Margin||78.69||81.19|
|Return on Assets||4.3||5.16|
|Return on Equity||6.66||10.14|
|Debt||Q2 FY19||Q2 FY18|
|Share Data||Q2 FY19||Q2 FY18|
|Shares outstanding (mil)||62.46||59.63|
|Div / share||0.0||0.0|
|Book value / share||10.57||9.41|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1206105.0||1169102.0|
BUY. MEDIDATA SOLUTIONS INC's P/E ratio indicates a significant premium compared to an average of 40.81 for the Other Information Services subsector and a significant premium compared to the S&P 500 average of 22.40. For additional comparison, its price-to-book ratio of 8.68 indicates a significant premium versus the S&P 500 average of 3.39 and a discount versus the subsector average of 8.71. The price-to-sales ratio is well above the S&P 500 average, but well below the subsector average.
|MDSO 129.23||Peers 64.30||MDSO 59.51||Peers 137.30|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
MDSO is trading at a significant premium to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
MDSO is trading at a significant discount to its peers.
|MDSO 43.90||Peers 43.23||MDSO 1.08||Peers 1.14|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
MDSO is trading at a premium to its peers.
Average. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
MDSO trades at a valuation on par to its peers.
|MDSO 8.68||Peers 8.71||MDSO -23.66||Peers -6.04|
Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
MDSO is trading at a valuation on par with its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, MDSO is expected to significantly trail its peers on the basis of its earnings growth rate.
|MDSO 8.37||Peers 10.17||MDSO 16.89||Peers 27.94|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
MDSO is trading at a discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
MDSO significantly trails its peers on the basis of sales growth.